AXON is expected to report earnings to rise+26% to 95 cents per share on May 06

A.I.dvisor
at Tickeron.com
05/05/24
Loading...
AXON - Axon Enterprise
Axon Enterprise Earnings Graph
Q1'24
Est.
$0.95
Q4'23
Missed
by $0.10
Q3'23
Beat
by $0.26
Q2'23
Beat
by $0.49
Q1'23
Beat
by $0.34
The last earnings report on December 31 showed earnings per share of 75 cents, missing the estimate of 85 cents. P/B Ratio (14.903) is normal, around the industry mean (6.674). AXON's P/E Ratio (137.900) is considerably higher than the industry average of (35.430). AXON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.862). AXON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (15.385) is also within normal values, averaging (4.679). With 279.18K shares outstanding, the current market capitalization sits at 24.04B.
View a ticker or compare two or three
AXONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry AerospaceDefense

Profile
Fundamentals
Details
Industry
Biotechnology
Address
17800 North 85th Street
Phone
+1 480 991-0797
Employees
4260
Web
https://investor.axon.com